Unicycive Therapeutics Inc. (UNCY)
NASDAQ · Healthcare
Unicycive Therapeutics Inc. Shareholder Equity 2022–2023
Unicycive Therapeutics Inc. annual/quarterly shareholder equity history from 2022 to 2023. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Unicycive Therapeutics Inc. shareholder equity for the quarter ending December 31, 2023 were -3.8M, a 717.38% increase year-over-year.
- Unicycive Therapeutics Inc. shareholder equity for 2023 were -3.8M, a 717.38% increase from 2022.
- Unicycive Therapeutics Inc. shareholder equity for 2022 were -466,000.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Unicycive Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2023 | $-4 |
| 2022 | $-0 |
| Unicycive Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2023-12-31 | $-4 |
| 2022-12-31 | $-0 |
Unicycive Therapeutics Inc. Shareholder Equity — FAQ
Unicycive Therapeutics Inc. (UNCY) shareholder equity over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see UNCY's shareholder equity history?
The chart and table above show Unicycive Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.